首页> 外国专利> Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Gene optimized Hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

机译:基因优化的汉坦病毒M段DNA疫苗用于肾综合征出血热

摘要

A synthetic, codon-optimized Hantaan virus (HTNV) full-length M gene open reading frame that consists of a unique nucleotide sequence encoding HTNV proteins. This synthetic gene was cloned into a plasmid to form the first optimized HTNV full-length M gene that elicits neutralizing antibodies in animals when delivered in combination with a similarly optimized Puumala virus (PUUV) DNA vaccine. The invention obviates the need for an extraneous gene sequence that was previously required for expression of the non-optimized HTNV gene. The synthetic gene is engineered into a molecular vaccine system to prevent hemorrhagic fever with renal syndrome (HFRS) caused by infection with HTNV, SEOV, or DOBV. Alternatively, it can be combined with the optimized PUUV DNA vaccine to protect against HFRS caused by any hantavirus.
机译:一种合成的,密码子优化的汉坦病毒(HTNV)全长M基因开放阅读框,该框架由编码HTNV蛋白的独特核苷酸序列组成。将该合成基因克隆到质粒中,形成第一个优化的HTNV全长M基因,当与类似的优化的Puumala病毒(PUUV)DNA疫苗联合递送时,该基因在动物中引起中和抗体。本发明消除了以前对于表达非优化的HTNV基因所需的外部基因序列的需要。合成基因被工程化到分子疫苗系统中,以预防由HTNV,SEOV或DOBV感染引起的肾综合征(HFRS)出血热。或者,可以将其与优化的PUUV DNA疫苗结合使用,以预防由汉坦病毒引起的HFRS。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号